Now in its 10th year, AusMedtech – regarded as Australia's premier medical technology conference – is being held in Melbourne from 24-25 May 2017.
Partnering for the first time with the International Conference on Mechanics in Medicine and Biology (ICMMB), AusMedtech 2017 aims to facilitate the development, growth and prosperity of the Australian medical technology (medtech) industry.
The Department of Jobs, Precincts and Regions (DJPR) welcomed over 400 international and local delegates to this year's conference – the largest exhibitor line-up to date – bringing together key stakeholders from the medical devices and diagnostics industries to explore topics such as biomaterials, medical devices, assisted technologies for an ageing population, tissue engineering, 3D printing and the mechanics of future medicine.
The Victorian Government is sponsoring the conference as part of its ongoing commitment to supporting innovation and the state's medtech sector. Since 2010, over A$1.8 billion has been invested in building Victoria's science and technology-based industries by providing funding assistance, key research and development (R&D) infrastructure, and a robust policy setting that encourages scientific endeavour, industry collaboration, product development, commercialisation and highly skilled manufacturing.
Victoria's medtech sector among the world's best
Victoria's medtech sector is made up of a sophisticated network of start-ups, medium-sized businesses, large multinationals, hospitals, service providers, universities and research organisations that translate cutting-edge research into real health and economic outcomes.
Reputed as Australia's premier hub for health and medical research – built on a long tradition in manufacturing – Victoria is unparalleled in Australia's medical technology, biotechnology and pharmaceutical sectors, and continues to flourish with revenues generated by Victorian companies tripling since 2003, producing a five-fold increase in exports, and currently providing jobs for over 23,000 people.
Home to 25 ASX-listed medtech companies with a combined market capitalisation of over A$5.6 billion, Victoria's medtech sector has an outstanding history of manufacturing, leading design and engineering, advanced medical research, technology transfer and commercialisation, and healthcare.
With global healthcare spending predicted to grow by more than 5 per cent annually, Victoria will be provided significant economic opportunities to develop and manufacture the new drugs, devices and digital solutions that will shape the future of healthcare.